427 related articles for article (PubMed ID: 33808504)
1. The Role of the Metzincin Superfamily in Prostate Cancer Progression: A Systematic-Like Review.
Binder MJ; Ward AC
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808504
[TBL] [Abstract][Full Text] [Related]
2. A complete expression profile of matrix-degrading metalloproteinases in Dupuytren's disease.
Johnston P; Chojnowski AJ; Davidson RK; Riley GP; Donell ST; Clark IM
J Hand Surg Am; 2007 Mar; 32(3):343-51. PubMed ID: 17336841
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs in non-neoplastic diseases.
Shiomi T; Lemaître V; D'Armiento J; Okada Y
Pathol Int; 2010 Jul; 60(7):477-96. PubMed ID: 20594269
[TBL] [Abstract][Full Text] [Related]
4. Expression profiling of metalloproteinases and their inhibitors in synovium and cartilage.
Davidson RK; Waters JG; Kevorkian L; Darrah C; Cooper A; Donell ST; Clark IM
Arthritis Res Ther; 2006; 8(4):R124. PubMed ID: 16859525
[TBL] [Abstract][Full Text] [Related]
5. Metalloproteinases and their tissue inhibitors in Alzheimer's disease and other neurodegenerative disorders.
Rivera S; García-González L; Khrestchatisky M; Baranger K
Cell Mol Life Sci; 2019 Aug; 76(16):3167-3191. PubMed ID: 31197405
[TBL] [Abstract][Full Text] [Related]
6. Extracellular regulation of metalloproteinases.
Yamamoto K; Murphy G; Troeberg L
Matrix Biol; 2015; 44-46():255-63. PubMed ID: 25701651
[TBL] [Abstract][Full Text] [Related]
7. The Many Facets of Metzincins and Their Endogenous Inhibitors: Perspectives on Ovarian Cancer Progression.
Escalona RM; Chan E; Kannourakis G; Findlay JK; Ahmed N
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393911
[TBL] [Abstract][Full Text] [Related]
8. Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis.
Milner JM; Rowan AD; Cawston TE; Young DA
Arthritis Res Ther; 2006; 8(5):R142. PubMed ID: 16919164
[TBL] [Abstract][Full Text] [Related]
9. Role of the netrin-like domain of procollagen C-proteinase enhancer-1 in the control of metalloproteinase activity.
Bekhouche M; Kronenberg D; Vadon-Le Goff S; Bijakowski C; Lim NH; Font B; Kessler E; Colige A; Nagase H; Murphy G; Hulmes DJ; Moali C
J Biol Chem; 2010 May; 285(21):15950-9. PubMed ID: 20207734
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases (MMPs) in health and disease: an overview.
Malemud CJ
Front Biosci; 2006 May; 11():1696-701. PubMed ID: 16368548
[TBL] [Abstract][Full Text] [Related]
11. Differential expressions of matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs and their endogenous inhibitors among histologic subtypes of lung cancers.
Hida Y; Hamada J
Anticancer Agents Med Chem; 2012 Sep; 12(7):744-52. PubMed ID: 22292754
[TBL] [Abstract][Full Text] [Related]
12. The Role of Tissue Inhibitors of Metalloproteinases in Organ Development and Regulation of ADAMTS Family Metalloproteinases in
Kubota Y; Nishiwaki K; Ito M; Sugimoto A
Genetics; 2019 Jun; 212(2):523-535. PubMed ID: 30992386
[TBL] [Abstract][Full Text] [Related]
13. A Disintegrin and Metalloproteinase (ADAM) and ADAM with thrombospondin motifs (ADAMTS) family in vascular biology and disease.
Zhong S; Khalil RA
Biochem Pharmacol; 2019 Jun; 164():188-204. PubMed ID: 30905657
[TBL] [Abstract][Full Text] [Related]
14. The evolution of the vertebrate metzincins; insights from Ciona intestinalis and Danio rerio.
Huxley-Jones J; Clarke TK; Beck C; Toubaris G; Robertson DL; Boot-Handford RP
BMC Evol Biol; 2007 Apr; 7():63. PubMed ID: 17439641
[TBL] [Abstract][Full Text] [Related]
15. The expression and regulation of ADAMTS-1, -4, -5, -9, and -15, and TIMP-3 by TGFbeta1 in prostate cells: relevance to the accumulation of versican.
Cross NA; Chandrasekharan S; Jokonya N; Fowles A; Hamdy FC; Buttle DJ; Eaton CL
Prostate; 2005 May; 63(3):269-75. PubMed ID: 15599946
[TBL] [Abstract][Full Text] [Related]
16. Transcriptomic mapping of the metzincin landscape in human trophoblasts.
Wächter J; Shannon MJ; Beristain AG
Gene Expr Patterns; 2022 Dec; 46():119283. PubMed ID: 36307023
[TBL] [Abstract][Full Text] [Related]
17. Metalloproteinases and metalloproteinase inhibitors in age-related diseases.
Gargiulo S; Gamba P; Poli G; Leonarduzzi G
Curr Pharm Des; 2014; 20(18):2993-3018. PubMed ID: 24079771
[TBL] [Abstract][Full Text] [Related]
18. Tissue inhibitors of metalloproteinases.
Murphy G
Genome Biol; 2011 Nov; 12(11):233. PubMed ID: 22078297
[TBL] [Abstract][Full Text] [Related]
19. Designing TIMP (tissue inhibitor of metalloproteinases) variants that are selective metalloproteinase inhibitors.
Nagase H; Brew K
Biochem Soc Symp; 2003; (70):201-12. PubMed ID: 14587293
[TBL] [Abstract][Full Text] [Related]
20. [Research progress of a disintegrin and metalloproteinase with thrombospondin motif 4 and 5 in osteoarthritis].
Ji Q; Zhang Q; Wang Y
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Sep; 27(9):1080-4. PubMed ID: 24279019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
